Literature DB >> 2120218

Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I.

J K Boyles1, L M Notterpek, L J Anderson.   

Abstract

In this report, we have identified two apolipoproteins (apo), apoD and apoA-IV, that, together with the previously identified apoA-I and apoE, accumulate in the regenerating peripheral nerve. These four apolipoproteins were identified in regenerating rat sciatic nerves by their molecular weights, their isoelectric points, and their recognition by specific antibodies. Antibodies were also used to document the changing concentrations of these apolipoproteins in homogenates of regenerating sciatic nerves collected 1 day to 6 weeks after a denervating crush injury. By 3 weeks after injury, at their peak accumulation, apoA-IV and apoA-I had increased 14- and 26-fold, respectively, relative to their concentrations in the normal nerve. Apolipoproteins D and E, in contrast, increased over 500- and 250-fold, respectively, by 3 weeks. These same apolipoproteins also accumulated in the regenerating sciatic nerves of two other species, the rabbit and the marmoset monkey. Immunocytochemistry showed that apoD was produced by astrocytes and oligodendrocytes in the normal central nervous system, and by neurolemmal or fibroblastic cells in the normal peripheral nervous system. Metabolic labeling of both apoD and apoE by [35S]methionine during an in vitro incubation of regenerating rat sciatic nerve segments confirmed that these apolipoproteins are synthesized by the nerve. Neither apoA-IV nor apoA-I was metabolically labeled, however, suggesting that they enter the nerve from the plasma. The results from this study provide evidence that several different apolipoproteins from various sources may play a role in lipid transport within neural tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  A human axillary odorant is carried by apolipoprotein D.

Authors:  C Zeng; A I Spielman; B R Vowels; J J Leyden; K Biemann; G Preti
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 3.  Regeneration of an adult peripheral nerve preparation in culture.

Authors:  M Kanje
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

Review 4.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

5.  CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment.

Authors:  Antonio Scollato; Alessandro Terreni; Anna Caldini; Benedetta Salvadori; Pasquale Gallina; Simona Francese; Guido Mastrobuoni; Giuseppe Pieraccini; Gloriano Moneti; Luca Bini; Gianni Messeri; Nicola Di Lorenzo
Journal:  Neurol Sci       Date:  2009-11-21       Impact factor: 3.307

6.  Apolipoprotein D: an overview of its role in aging and age-related diseases.

Authors:  Julien Muffat; David W Walker
Journal:  Cell Cycle       Date:  2010-01-26       Impact factor: 4.534

Review 7.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

8.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease.

Authors:  S C Patel; S Suresh; U Kumar; C Y Hu; A Cooney; E J Blanchette-Mackie; E B Neufeld; R C Patel; R O Brady; Y C Patel; P G Pentchev; W Y Ong
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Post-translational modifications of apolipoprotein A-I and Po proteins in the avian peripheral nerve.

Authors:  J Lemieux; S Giannoulis; W C Breckenridge; C Mezei
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

10.  Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila.

Authors:  Julien Muffat; David W Walker; Seymour Benzer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.